NCI-TARGET About us

NCI-TARGET mainly uses the compounds of protein group Concanavalin-A (referred to as Con-A JDFL) extracted from the North American origin beans and jack beans. It can kill the virus and improve the human immune system and the anti-cancer ability quickly by special cells.
Con A, The Nobel honor

Over the past one hundred years, the study on North American origin beans by Dr. Sumner was an important milestone, who was the winner of the Nobel Prize in 1946. Afterwards, medical study articles over hundred were published by famous journals such as Nature, Science, Cancer and so on. However, any patent is not awarded.
In 2004, NCI-TARGET / Treatment has taken out the medical patent of "Anti-cancer Agent" (Anti-tumor Composition) in USA. Its non-toxic anti-cancer effects (LD50 = 4000mg) have been proved by the animal test models separately from the cancer clinical trial and the anti-cancer treatment, and it can be used for clinical purposes or human consumptions. In addition, it is effective for liver function (GOT / AST, GPT / ALT index), renal (BUN, Creatinine index and uric acid gout), long-term stomach pain or hematopoietic function (platelet / white blood cells) and gynecological fields. It is a special medical technology in the world.
.
 

         放大顯示              

Most recent news
In 2004, NCI-TARGET / Treatment has taken out the medical patent of "Anti-cancer Agent" (Anti-tumor Composition) in USA. Its non-toxic anti-cancer effects (LD50 = 4000mg) have been proved by the animal test models separately from the cancer clinical trial and the anti-cancer treatment, and it can be used for clinical purposes or human consumptions. In addition, it is effective for liver function (GOT / AST, GPT / ALT index), renal (BUN, Creatinine index and uric acid gout), long-term stomach pain or hematopoietic function (platelet / white blood cells) and gynecological fields. It is a special medical technology in the world.
 
NCI-Target Efficacy Mechanism
NCI-Target Clinical Performance
Improve Your Body
Test Result for Cancer
Who and How Use It
 
© 2010 NCI target | All right reserved